AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Interventional Study on Smoking Reduction in Psychiatry

RecruitingNAAges 18 Years - anyAllGCS-CCOMS
💬

In plain words

What the trial is, and whether it could suit you

The smoking rate among people with mental disorders is higher than in the general population. Greater exposure to the harmful effects of tobacco partly explains the major inequality in life expectancy observed among people with mental disorders who, depending on the disorder and the study, live 10 to 25 years less than the general population, a gap mainly due to the occurrence of cardiovascular and respiratory pathologies, notably bronchial cancers. However, tobacco reduction actions specifically targeting these people remain insufficiently developed, particularly in psychiatry where this addiction is often banalized and its treatment neglected. The objective of this study is to evaluate an intervention ('Tabapsy') co-constructed with mental health services users, mental health professionals, and general practitioners and targeting adult patients followed in ambulatory psychiatry. The m

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Regular smokers (at least one cigarette per day) * Followed in psychiatric ambulatory care at one of the participating sectors' CMPs * Adults (18 years or older) * Covered by the statuary health insurance * Who gave their informed consent to participate to the study Exclusion Criteria: * Users under guardianship or legal protection, * Psychological state incompatible with completing the questionnaire, * Persons with no command or understanding of the French language
💊

What it tests

  • TABAPSY
  • Usual Care
📍

Where

22 sites
Public mental health establishment of Lille Metropole (59G16-G17)
Armentières, France
Public mental health establishment of Lille Metropole (59G21)
Armentières, France
Flanders public mental health establishment (59G05/06)
Bailleul, France
Barthelemy Durand public health establishment (91G05)
Étampes, France
Psychotherapeutic center of Nancy (54G02-06)
Laxou, France
University Hospital Center of Lille (59G08)
Lille, France
Hospital Care Center of Nanterre (92G10)
Nanterre, France
University Hospital Group Paris Neurosciences & Psychiatry (75G04)
Paris, France

…and 14 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy